Catalog number: 1142 - PP-0005-2ML
Product Category: Business & Industrial > Science & Laboratory
Size: 2mL
PP-0001-10ML
DOPC/DSPE-mPEG2000 (95/5, mol/mol) Liposomes, 30 mM, extruded and supplied sterile-filtered in glass vial.
PP-0001-2ML
DOPC/DSPE-mPEG2000 (95/5, mol/mol) Liposomes, 30 mM, extruded and supplied sterile-filtered in glass vial.
PP-0002-10ML
DSPC/DSPE-mPEG2000 (95/5, mol/mol) Liposomes, 30 mM, extruded and supplied sterile-filtered in glass vial.
DLL-0019-1A-5MG
PEGylated liposomes containing Rocaglamide (Roc-A). Rocaglamide is a potent inhibitor of NF-κB activation in T-cells. Rocaglamide is a potent and selective HSF1 activation inhibitor (IC50 ~50 nM). Rocaglamide inhibits the function of the translation initiation factor eIF4A. Rocaglamide also exhibits anti-leukemia activity. Rocaglamide is insoluble in aqueous media. This product is a pre-formulated liposomal version of Rocaglamide which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
DLL-0023-1A-10ML
PEGylated liposomes containing AZD1208. AZD1208 is a potent Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. AZD1208 induces autophagy, cell cycle arrest and apoptosis. This product is a pre-formulated liposomal version of AZD1208 which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
DLL-0023-1A-20ML
PEGylated liposomes containing AZD1208. AZD1208 is a potent Pim kinase inhibitor with IC50 of 0.4 nM, 5 nM, and 1.9 nM for Pim1, Pim2, and Pim3 in cell-free assays, respectively. AZD1208 induces autophagy, cell cycle arrest and apoptosis. This product is a pre-formulated liposomal version of AZD1208 which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.